000 | 01591 a2200457 4500 | ||
---|---|---|---|
005 | 20250513105139.0 | ||
264 | 0 | _c19961227 | |
008 | 199612s 0 0 eng d | ||
022 | _a0022-1767 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSkipper, J C | |
245 | 0 | 0 |
_aShared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from Pmel-17/gp100. _h[electronic resource] |
260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cDec 1996 |
||
300 |
_a5027-33 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAmino Acid Sequence |
650 | 0 | 4 |
_aAntigens, Neoplasm _xgenetics |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aEpitopes _xgenetics |
650 | 0 | 4 | _aHLA-A3 Antigen |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aMelanoma _ximmunology |
650 | 0 | 4 |
_aMembrane Glycoproteins _xgenetics |
650 | 0 | 4 |
_aNeoplasm Proteins _xgenetics |
650 | 0 | 4 |
_aPeptide Fragments _xgenetics |
650 | 0 | 4 | _aProtein Processing, Post-Translational |
650 | 0 | 4 |
_aProteins _xgenetics |
650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
650 | 0 | 4 | _agp100 Melanoma Antigen |
700 | 1 | _aKittlesen, D J | |
700 | 1 | _aHendrickson, R C | |
700 | 1 | _aDeacon, D D | |
700 | 1 | _aHarthun, N L | |
700 | 1 | _aWagner, S N | |
700 | 1 | _aHunt, D F | |
700 | 1 | _aEngelhard, V H | |
700 | 1 | _aSlingluff, C L | |
773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 157 _gno. 11 _gp. 5027-33 |
|
999 |
_c8935722 _d8935722 |